Internal Medicine, Interventional Cardiology · Peoria, AZ
NPI
1437147477
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
13460 N 94th Dr Ste J1
Peoria, AZ, 85381
Phone (623) 876-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$695K
12,536 services
Medicare patients, 2024
1,382
Average age 79
Drug cost, 2024
$1.7M
10,197 prescriptions
Company payments, 2025
$1,116
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vishal B Patel was code 99214 (office e&m - established), 2,022 times for 1,031 patients. In total Vishal B Patel billed 12,536 services in 73 codes, and Medicare paid $695K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,022 | 1,031 | $95.35 | $193K |
| 93000 Electrocardiogram | Office | 1,835 | 1,097 | $10.82 | $20K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,154 | 99 | $39.71 | $46K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 924 | 116 | $51.31 | $47K |
| 99454 E&M - Miscellaneous | Office | 753 | 83 | $38.13 | $29K |
| 99211 Office E&M - Established | Office | 541 | 133 | $17.69 | $9,570 |
| 93306 Echocardiography (TTE/TEE) | Office | 430 | 414 | $153.68 | $66K |
| 99213 Office E&M - Established | Office | 414 | 363 | $72.51 | $30K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 389 | 98 | $5.76 | $2,240 |
| 36415 Venipuncture Blood Collection | Office | 341 | 177 | $8.65 | $2,950 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 322 | 162 | $75.97 | $24K |
| 80053 Clinical Chemistry | Office | 316 | 160 | $10.35 | $3,271 |
| 85610 Clinical Chemistry | Office | 287 | 43 | $4.20 | $1,205 |
| 99457 E&M - Miscellaneous | Office | 287 | 72 | $39.33 | $11K |
| 93296 External Electrocardiographic Monitoring | Office | 197 | 65 | $15.80 | $3,112 |
By year: 2022 $756K for 14,934 services; 2023 $758K for 14,257 services; 2024 $695K for 12,536 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 341 | 177 | $8.65 | $2,950 |
| 80053 Clinical Chemistry | 316 | 160 | $10.35 | $3,271 |
| 85610 Clinical Chemistry | 287 | 43 | $4.20 | $1,205 |
| 85025 Blood Count | 132 | 100 | $7.61 | $1,005 |
| 83880 Clinical Chemistry | 128 | 39 | $38.47 | $4,924 |
| 80061 Clinical Chemistry | 26 | 19 | $13.12 | $341 |
Medicare prescription drug claims, 2024
In 2024, the drug Vishal B Patel prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,050 prescriptions and refills. In total Vishal B Patel wrote 10,197 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,050 | 2,240 | 268 | $1.3M |
| Metoprolol Succinate Generic | 921 | 2,650 | 288 | $13K |
| Furosemide Generic | 644 | 1,687 | 226 | $2,937 |
| Carvedilol Generic | 544 | 1,569 | 161 | $6,148 |
| Losartan Potassium Generic | 505 | 1,411 | 158 | $5,641 |
| Metoprolol Tartrate Generic | 480 | 1,376 | 160 | $3,010 |
| Amlodipine Besylate Generic | 449 | 1,254 | 138 | $2,402 |
| Lisinopril Generic | 434 | 1,255 | 142 | $3,596 |
| Atorvastatin Calcium Generic | 338 | 988 | 110 | $3,623 |
| Hydrochlorothiazide Generic | 270 | 683 | 90 | $1,177 |
| Clopidogrel Clopidogrel Bisulfate | 255 | 749 | 89 | $3,178 |
| Valsartan Generic | 255 | 745 | 78 | $4,882 |
| Nifedipine Er Nifedipine | 224 | 623 | 69 | $7,990 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 213 | 595 | 66 | $7,686 |
| Potassium Chloride Generic | 199 | 512 | 67 | $3,609 |
Brand drugs: 1,582 claims; generic drugs: 8,615 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vishal B Patel $1,116 ($1,116 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbott Laboratories with $303.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 7 | $303 |
| Abiomed JNJ | 10 | $238 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $124 |
| Cleerly, Inc. | 2 | $109 |
| Boston Scientific Corporation BSX | 2 | $97.32 |
| Pfizer Inc. PFE | 4 | $71.87 |
| Inspire Medical Systems, Inc. INSP | 3 | $60.02 |
| Merck Sharp & Dohme LLC MRK | 2 | $55.3 |
| Astellas Pharma US Inc 4503.T | 1 | $32.99 |
| Medtronic, Inc. MDT | 1 | $24.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.